Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-14

Clinical Trial Update: Dose Response Relationship of Oxytocin on Irritability in Youths [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update examining how varying doses of oxytocin affect irritability in youths. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University of Nebraska | Conditions: Irritable Mood | Phase 1, Phase 2 | Status: TERMINATED